The A-share innovative drug sector saw an initial correction, with Hainan Haiyao hitting its daily limit down, followed by declines in Shuanglu Pharmaceutical, Xin Ganjiang, Sanyuan Gene, Heyi Pharmaceutical, and 3SBio.

2026-07-07

The A-share innovative drug sector saw an initial correction, with Hainan Haiyao hitting its daily limit down, followed by declines in Shuanglu Pharmaceutical, Xin Ganjiang, Sanyuan Gene, Heyi Pharmaceutical, and 3SBio.